Industry

Tremeau is presenting two abstracts, highlighting the following: TRM-201 achieves comparable exposures of rofecoxib at a lower nominal dose (17.5 mg) compared to historical VIOXX 25 mg Rofecoxib’s favorable gastrointestinal tolerability profile enabled chronic off-label use of VIOXX’s acute dose (50 mg), leading to a perception of a unique CV safety risk CONCORD, Mass.–(BUSINESS WIRE)–Tremeau … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that its abstract highlighting data from the ongoing Phase 2a study of VBI-1901, the Company’s cancer vaccine immunotherapeutic candidate in recurrent glioblastoma (GBM), was accepted for poster presentation at … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “CRISPR and CAS Genes Market Analysis by Product & Service, by Application by End user, and by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The CRISPR and CAS genes market size is estimated to be USD 1095 million in 2021 and is expected to witness a CAGR … [Read more…]

CareDx Leads Scientific Evidence with Over 100 Peer-Reviewed Publications Supporting the Clinical Use of AlloSure and AlloMap for Organ Transplant Patients BRISBANE, Calif.–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced the five-year anniversary … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Proteomic Biomarker Analytics Markets. Forecasts by Application, Technology, Product and Place. With Executive and Consultant Guides, Including Customized Forecasting and Analysis. 2022 to 2026” report has been added to ResearchAndMarkets.com’s offering. Proteomics is going mainstream. Where genomics couldn’t find all the answers proteomics is stepping up to the plate. Who will be the … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Endoscopy Visualization Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update” report has been added to ResearchAndMarkets.com’s offering. Scope of the report Extensive coverage of the Endoscopy Visualization Systems under development The report reviews details of major pipeline products which includes, product description, licensing … [Read more…]

FORT WORTH, Texas–(BUSINESS WIRE)–NanOlogy LLC, a clinical-stage interventional oncology drug company, announced enrollment is complete in a Phase 2a trial of intratumoral (IT) large surface area microparticle paclitaxel (LSAM-PTX) with standard of care (SOC) therapy in patients with nonoperable lung cancer. The single arm trial (NCT04314895) enrolled 18 subjects at four clinical sites with primary … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Precision Diagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type, Application, and End User” report has been added to ResearchAndMarkets.com’s offering. The precision diagnostics market in Asia Pacific is expected to grow from US$ 15,157.61 million in 2022 to US$ 33,007.52 million by 2028. It is … [Read more…]

− LIVTENCITY Is the First and Only Treatment Approved for This Indication by the EC1 − CMV Is One of the Most Common and Serious Post-transplant Infections and Can Lead to Loss of Transplanted Organ and Failure of Graft 2,3 OSAKA, Japan & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Takeda (TSE:4502/NYSE:TAK) today announced that the European Commission (EC) has … [Read more…]

NEW HAVEN, Conn.–(BUSINESS WIRE)–Rallybio Corporation (“Rallybio”) (Nasdaq: RLYB) today announced the pricing of an underwritten public offering of 5,000,001 shares of its common stock at a price to the public of $6.00 per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase up to an aggregate of 3,333,388 shares of … [Read more…]